Health Boards
Sat-13-08-2022, 10:33 AM
Update: The U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis.
|
Tremfya going after psoriatic arthritis
|
Sun-14-08-2022, 18:18 PM
To be honest, non of the IL23s seem to work for the back, at least not for me.
 (Sun-14-08-2022, 18:18 PM)mataribot Wrote: To be honest, non of the IL23s seem to work for the back, at least not for me. I can imagine that. Personally I have the idea that the IL23’s are more related to psoriasis and that the IL17’s and IL17A’s are more related to Psoriatic Arthritis. Considering all the examples over here on psoriasisclub. |
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Could c-reactive protein predict psoriatic arthritis | Fred | 7 | 609 |
Mon-07-04-2025, 13:15 PM Last Post: Forest Walker |
|
|
Tremfya & Skyrizi in psoriasis patients with HIV | Fred | 0 | 200 |
Thu-03-04-2025, 15:57 PM Last Post: Fred |
|
|
Tremfya Japanese safety and efficacy study | Fred | 0 | 221 |
Sat-29-03-2025, 12:33 PM Last Post: Fred |
|
|
Treatment goals with psoriatic arthritis | Fred | 5 | 745 |
Thu-27-03-2025, 04:29 AM Last Post: mataribot |
|
|
Cosentyx and erosion progression in psoriatic arthritis | Fred | 0 | 331 |
Fri-14-03-2025, 12:03 PM Last Post: Fred |
Users browsing this thread: 2 Guest(s)